AN2 Therapeutics Inc. (ANTX) SEC News June 18, 2025, 15:08 UTC New Form SCHEDULE 13D/A - AN2 Therapeutics, Inc. Filed: 2025-06-18 AccNo: 0001373604-25-000092 Size: 8 KB Full text
There are no comments here yet...